V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002030 | 330001150 | 1.85 | 84.1 | Curative (C) | 2015-10-21 | 2015-10-22 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330007731 | NOT MATCHED |
| 330002031 | 330001151 | null | 108 | Curative (C) | 2016-09-21 | 2016-09-21 | NB HRNBL-1 COJEC Ind COURSE A | N | N | 330007737 | NOT MATCHED |
| 330002032 | 330001152 | 1.64 | 66.45 | Curative (C) | 2017-05-31 | 2017-06-01 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007739 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002033 | 330001152 | 1.8 | 71.4 | Curative (C) | 2016-07-24 | 2016-08-19 | Cisplatin | N | Y | 330007739 | CISPLATIN |
| 330002035 | 330001154 | 1.7 | 74 | Neo-adjuvant (N) | 2015-11-03 | 2015-11-03 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007747 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002036 | 330001154 | null | 81.4 | Neo-adjuvant (N) | 2014-07-16 | 2014-07-16 | ALL Interfant 06 MAE | N | N | 330007747 | NOT MATCHED |
| 330002037 | 330001154 | 1.7 | 110 | Neo-adjuvant (N) | 2016-06-06 | 2016-06-13 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007747 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002038 | 330001154 | 1.81 | 109.2 | Curative (C) | 2014-03-23 | 2014-04-07 | Cisplatin + Docetaxel +Fluorouracil | null | null | 330007747 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002039 | 330001155 | null | 0 | Curative (C) | 2015-08-21 | 2016-01-13 | NB HRNBL | Y | N | 330007758 | NOT MATCHED |
| 330002040 | 330001156 | 1.55 | 91 | Curative (C) | 2014-06-25 | 2014-06-25 | Cisplatin 7 day | 02 | null | 330007763 | CISPLATIN |
| 330002041 | 330001157 | 0 | 45 | Curative (C) | 2017-05-04 | 2017-05-04 | OST Euramos 1 Closed Trial - Ai | Y | N | 330007765 | NOT MATCHED |
| 330002042 | 330001158 | 0 | 7.5 | Curative (C) | null | 2015-01-16 | CNS GCT II Non Germin - Std PEI | 02 | null | 330007769 | NOT MATCHED |
| 330002043 | 330001159 | 1.6 | null | Curative (C) | 2015-03-20 | 2015-03-21 | Cisplatin | 02 | null | 330007773 | CISPLATIN |
| 330002044 | 330001160 | null | 20.6 | Curative (C) | 2016-08-28 | 2016-08-28 | WT SIOP 2002 01 post op Carbo, Etop | N | N | 330007774 | NOT MATCHED |
| 330002045 | 330001160 | 1.7 | 59 | Neo-adjuvant (N) | null | 2014-08-13 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 330007774 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002046 | 330009569 | 1.77 | 101.2 | Curative (C) | 2015-06-01 | 2015-06-14 | CNS GCT II | Y | null | 330007776 | NOT MATCHED |
| 330002047 | 330001161 | 0 | 61.9 | Curative (C) | null | 2016-11-30 | EW EuroEwing 2012 Arm B VDC | Y | N | 330007778 | TRIAL |
| 330002048 | 330001161 | 0 | 76 | null | 2016-05-28 | 2016-05-28 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330007778 | NOT MATCHED |
| 330002049 | 330001162 | 1.79 | 27.8 | Adjuvant (A) | 2013-02-26 | 2013-02-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 330007780 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002050 | 330001163 | 1.78 | 74 | null | 2017-10-04 | 2017-10-07 | Trial Unspecified | Y | null | 330007787 | TRIAL |
| 330002051 | 330001164 | null | null | Curative (C) | 2016-12-03 | 2016-12-15 | NB HRNBL-1 MOD N7 CAV | N | N | 330007788 | NOT MATCHED |
| 330002052 | 330001165 | 0 | 81.4 | Curative (C) | 2015-08-17 | 2015-08-21 | CISPLATIN + DACTINOMYCIN + ETOPOSIDE + FILGRASTIM + METHOTREXATE | 1 | null | 330007794 | NOT MATCHED |
| 330002053 | 330001165 | 1.43 | 49.9 | Adjuvant (A) | 2014-02-20 | 2014-03-11 | Cisplatin 7 day | N | Y | 330007794 | CISPLATIN |
| 330002054 | 330001165 | null | 85.7 | Adjuvant (A) | null | 2013-04-07 | Cisplatin | N | Y | 330007794 | CISPLATIN |
| 330002055 | 330001165 | 1.5 | 74.8 | null | 2017-03-13 | 2017-03-26 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330007794 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002056 | 330001166 | 0 | null | Palliative (P) | 2014-11-15 | 2014-12-13 | EW EuroEwing 2012 Arm B VDC | N | N | 330007807 | TRIAL |
| 330002057 | 330001167 | 0 | 62.1 | Curative (C) | 2014-05-25 | 2014-05-26 | Rucaparib | Y | N | 330007812 | TRIAL |
| 330002058 | 330001167 | 1.26 | null | Curative (C) | 2016-06-19 | 2016-06-19 | EW EuroEwing 2012 Arm A/B Zol Acid | 02 | N | 330007812 | NOT MATCHED |
| 330002059 | 330001167 | 1.26 | null | Curative (C) | 2015-12-20 | 2015-12-23 | NB HRNBL-1 COJEC Ind COURSE A | Y | N | 330007812 | NOT MATCHED |
| 330002060 | 330001168 | 1.8 | 15.3 | Curative (C) | 2015-06-06 | 2015-07-06 | Cisplatin | 02 | Y | 330007824 | CISPLATIN |
| 330002063 | 330001170 | 1.8 | 55.55 | Curative (C) | null | 2017-10-13 | Cisplatin | N | Y | 330007829 | CISPLATIN |
| 330002064 | 330001171 | 1.1 | 59 | Neo-adjuvant (N) | 2017-01-11 | 2017-01-12 | NB HRNBL-1 COJEC Ind COURSE A | Y | null | 330007831 | NOT MATCHED |
| 330002065 | 330001171 | null | 71 | Curative (C) | 2016-03-04 | 2016-03-30 | Cisplatin | N | Y | 330007831 | CISPLATIN |
| 330002066 | 330001172 | null | 52.6 | Palliative (P) | 2016-02-11 | 2016-03-03 | null | N | 2 | 330007845 | NOT MATCHED |
| 330002067 | 330001173 | 1.9 | 10 | Neo-adjuvant (N) | 2017-01-19 | 2017-01-20 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 330007847 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002068 | 330001173 | 1.86 | 103 | Disease modification (D) | 2016-11-22 | 2016-11-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330007847 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002069 | 330001173 | 1.8 | null | Curative (C) | 2013-09-03 | 2013-09-04 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007847 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002070 | 330001174 | 0 | 70 | Palliative (P) | 2018-04-06 | 2018-04-17 | WT SIOP 2002 01 post op Carbo, Etop | N | N | 330007856 | NOT MATCHED |
| 330002071 | 330001174 | null | 58.7 | Curative (C) | 2018-02-09 | 2018-02-14 | Bortezomib + RITUXIMAB + THALIDOMIDE | 02 | N | 330007856 | NOT MATCHED |
| 330002072 | 330001175 | null | 59 | Neo-adjuvant (N) | 2015-08-05 | 2015-08-17 | NB HRNBL-1 BUMEL MAT | Y | N | 330007863 | NOT MATCHED |
| 330002073 | 330001176 | 1.6 | 16.1 | Adjuvant (A) | 2014-10-01 | 2014-10-27 | Cisplatin 7 day | N | Y | 330007870 | CISPLATIN |
| 330002074 | 330001176 | 1.84 | 72.8 | Adjuvant (A) | 2015-10-28 | 2015-11-09 | EW EuroEwing 2012 Arm B VDC | Y | Y | 330007870 | TRIAL |
| 330002075 | 330001177 | null | 6.8 | Neo-adjuvant (N) | 2017-12-06 | 2017-12-07 | Cisplatin 7 day | N | Y | 330007874 | CISPLATIN |
| 330002076 | 330001177 | null | 21.4 | Neo-adjuvant (N) | 2017-06-14 | 2017-06-21 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 330007874 | NOT MATCHED |
| 330002077 | 330001177 | 1.66 | 60.1 | Curative (C) | 2015-04-24 | 2015-05-01 | Cisplatin 7 day | null | Y | 330007874 | CISPLATIN |
| 330002078 | 330001177 | 1.79 | 54.7 | Curative (C) | 2015-11-22 | 2015-12-13 | Cisplatin | N | Y | 330007874 | CISPLATIN |
| 330002079 | 330001178 | 1.63 | 56.2 | Neo-adjuvant (N) | 2017-05-05 | 2017-05-07 | Cisplatin + Docetaxel +Fluorouracil | null | N | 330007888 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330002080 | 330001178 | 1.75 | 56 | Neo-adjuvant (N) | null | 2014-07-09 | Trial Unspecified | Y | N | 330007888 | TRIAL |
| 330002081 | 330001178 | null | 61.2 | Curative (C) | 2015-03-20 | 2015-03-20 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 2 | N | 330007888 | NOT MATCHED |
| 330002082 | 330001179 | 1.66 | 92.05 | Curative (C) | 2013-09-11 | 2013-10-21 | Cisplatin | N | Y | 330007892 | CISPLATIN |